drugset / Trial / NCT02376972
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
RandomizedParallel-groupTriple-blindTreatment
Summary
THE STUDY HAS BEEN DESIGNED TO COMPARE THE EFFICACY OF TWO DOSES (25 MG AND 100 MG) OF RIFAXIMIN VAGINAL TABLETS VERSUS PLACEBO IN SUBJECTS WITH BACTERIAL VAGINOSIS
Timeline
- Start
- 2015-04
- Primary completion
- 2016-02
- Completion
- 2016-02
Outcome
Outcome not reported
Stopped: “According to the Recommendation of the Indipendent Data Monitoring Committee”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metronidazole | Small molecule | — | Other |
| Subject | Rifaximin | Other / unclassified | 25 mg | Other |
| Subject | Rifaximin | Other / unclassified | 100 mg | Other |